Skip to content
DataLookout
Menu

NCT07894497

Ivarmacitinib With or Without Celecoxib for Ankylosing Spondylitis

StatusNot Yet Recruiting
PhasePhase 4
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 1 with changes below, 1 re-verified with no change.

  1. Study First Submitted

Endpoints

Primary

Proportion of participants achieving an ASAS20 response at week 24.
Timeframe: Week 24

Arms and interventions

Ivarmacitinib with CelecoxibExperimental
IvarmacitinibActive comparator

Drugs: Ivarmacitinib with celecoxib, Ivarmacitinib Monotherapy